TABLE 1

Serial induced sputum sampling methodologies and results

ParameterInduced sputum number
123
Microbiological results
 Positive smear12 (6%)10 (5%)7 (4%)
 Positive culture#160 (80%)163 (82%)142 (71%)
 Colony count20 (3–100)20 (2–100)18 (2–100)
Induction methodology
 Bronchodilator pre-treatment34 (17%)24 (12%)19 (10%)
 Airway clearance device+198 (99%)158 (79%)160 (80%)
 Hypertonic saline concentration
  3%10 (5%)6 (3%)8 (4%)
  7%131 (66%)126 (63%)116 (58%)
  10%59 (30%)68 (34%)76 (38%)
Incremental detection yields and selected sub-group comparisons
 All patients160 (80%)27 (14%)13 (6%)
 Single species (n=173)135 (78%)25 (14%)13 (8%)
 Pulmonary cavitation§
  Present (n=51)47 (92%)4 (8%)N/A
  Absent (n=149)113 (76%)23 (15%)13 (9%)
 Current treatment
  Present (n=57)45 (79%)8 (14%)4 (7%)
  Absent (n=143)115 (80%)19 (13%)9 (6%)
 Inhaled corticosteroidsƒ
  Present (n=44)31 (70%)7 (16%)6 (14%)
  Absent (n=156)129 (83%)20 (13%)7 (4%)

Data are presented as n (%) or median (interquartile range). #: rates of culture positivity differed with sputum number (p=0.03); : there was a trend towards differing of rates of bronchodilator pre-treatment with sputum number (p=0.08); +: rates of airway clearance device (Aerobika or vest) use during induction differed with sputum number (p<0.001); §: detection yields differed with present/absent cavitation (p=0.02); ƒ: there was a trend towards differing of detection yields with present/absent inhaled corticosteroid use (p=0.07).